NEOGEN Neogen Chemicals Q3 FY26 results (Oct–Dec 2025) and concall
Neogen Chemicals reported a 9% YoY revenue growth in Q3 FY26, reaching INR 220 crore, alongside a 13% increase in gross profit. However, profitability was impacted by transient costs from the Neogen Ionics ramp-up, fire incident, and higher finance expenses. The company is actively advancing its battery materials strategy through a new JV with Morita and the Pakhajan greenfield project, with significant funding expected from insurance claims, the JV partner, and promoters to support future growth.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue down 63.6%, net profit down 35.7% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|
| Revenue | 22 | -3 | 5 | 7 | 8 −64% |
| EBITDA | 38 | 41 | 35 | 35 | 36 −5% |
| Net profit | 14 | 5 | 14 | 9 | 9 −36% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
